Patents by Inventor Antoine Garbarg-Chenon

Antoine Garbarg-Chenon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of making novel erythrovirus V9 VP2 capsid polypeptides
    Patent number: 8105610
    Abstract: The invention relates to nucleic sequences derived from a human erythrovirus type V9, fragments of the sequences and their methods of use including applications as a diagnostic reagent and as immunogenic agent.
    Type: Grant
    Filed: October 5, 2007
    Date of Patent: January 31, 2012
    Assignee: Assistance Publique Hospitaux de Paris
    Inventors: Quang Tri Nguyen, Antoine Garbarg-Chenon, Véronique Auguste
  • Preparation of recombinant rotavirus proteins in milk of transgenic non-human mammals
    Publication number: 20100028371
    Abstract: The present invention relates to a non-human transgenic mammal whose genome comprises: i) a first transgene comprising a mammary gland specific transcriptional control region operably linked to cDNA encoding a rotavirus protein selected from VP2, VP4, VP6 and VP7 and wherein said cDNA comprises a secretion signal sequence; ii) at least a second transgene comprising a mammary gland specific transcriptional control region operably linked to cDNA encoding another said rotavirus protein and wherein said cDNA comprises a secretion signal sequence; and wherein said rotavirus proteins are secreted separately and auto-assembled in milk in rotavirus like particles (VLP) or aggregates of said rotavirus proteins.
    Type: Application
    Filed: March 4, 2005
    Publication date: February 4, 2010
    Inventors: Jean Cohen, Eric Soler, Louis-Marc Houdebine, Isabelle Schwartz-Cornil, Cynthia Fourgeux, Nathalie Parez, Antoine Garbarg-Chenon, Ivan Cohen, Serge Cohen
  • Erythrovirus and its applications
    Patent number: 7291452
    Abstract: The invention concerns nucleic acids derived from human V9 erythrovirus, fragments thereof, encoded polypeptides, and applications as diagnostic reagents and as immunogenic agents.
    Type: Grant
    Filed: December 3, 1998
    Date of Patent: November 6, 2007
    Assignee: Assistance Publique Hopitaux de Paris
    Inventors: Quang Tri Nguyen, Antoine Garbarg-Chenon, Véronique Auguste